| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |